Ascendis Pharma A (ASND) Current Taxes (2012 - 2026)

Ascendis Pharma A has disclosed Current Taxes across 15 years of filings, most recently posting $9.1 million for Q1 2026.

• Current Taxes for Q1 2026 came in at $9.1 million, up 452.25% year-over-year; the trailing twelve-month figure through Mar 2026 was $9.1 million (up 452.25% YoY), and the FY2025 annual result was $7.5 million, up 472.92% from the prior year.
• Current Taxes came in at $9.1 million for Q1 2026 at Ascendis Pharma A, up from $7.5 million in the prior quarter.
• In the past five years, Current Taxes ranged from a high of $9.1 million in Q1 2026 to a low of $96035.1 in Q2 2022.
• The 5-year median for Current Taxes is $1.9 million (2025), against an average of $3.4 million.
• Across the five-year window, Current Taxes jumped 6445.9% in 2023 and sank 84.18% in 2024, its largest moves.
• Ascendis Pharma A's Current Taxes stood at $5.6 million in 2022, then plunged by 55.84% to $2.5 million in 2023, then sank by 47.21% to $1.3 million in 2024, then surged by 472.92% to $7.5 million in 2025, then climbed by 22.14% to $9.1 million in 2026.
• The last three Current Taxes figures came in at $9.1 million (Q1 2026), $7.5 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.